Bayer awarded Amerinet deal

Bayer HealthCare Pharmaceuticals of Wayne, NJ, has received a two-year supply contract for its Magnevist and Ultravist contrast agents from group purchasing organization Amerinet.

The agreement is in effect through 2010 and covers both Magnevist (gadopentetate dimeglumine) and Ultravist (iopromide) in multiple quantities. The St. Louis-based Amerinet serves more than 26,000 acute and nonacute healthcare providers nationwide.

Related Reading

Bayer announces ship date for VistaTrak, March 13, 2008

Bayer inks molecular imaging deal, February 20, 2008

Bayer launches VistaTrak at RSNA show, December 3, 2007

Bayer HealthCare secures 3-year MRI contract, November 9, 2007

Bayer Schering Pharma licenses Avid's imaging agent, June 19, 2007

Copyright © 2008

Page 1 of 590
Next Page